- The global DiGeorge Syndrome Drug Market is expected to register significant growth in the forecast period of 2025 to 2032. Data Bridge Market Research analyzes the market to grow at a CAGR of 6.5% during this period.
- DiGeorge syndrome, also known as 22q11.2 deletion syndrome, is a rare genetic disorder that can cause heart defects, poor immune function, cleft palate, and low levels of calcium in the blood. Early diagnosis and comprehensive treatment are critical to managing symptoms and improving quality of life.
- Factors such as the increasing prevalence of congenital disorders, expanding research on rare diseases, supportive healthcare policies, and growing investments in orphan drug development are accelerating market growth globally
